| Financial Year |
March 31 2023 |
| Monetary Funds |
895,042,614.21 |
| Held-for-trading Financial Assets |
666,174,205.86 |
| Notes Receivable |
141,559,200.00 |
| Accounts Receivable |
161,367,982.62 |
| Advances to Suppliers |
57,956,570.10 |
| Other Receivables |
21,864,782.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
778,696,095.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
226,073,111.82 |
| Other Current Assets |
33,978,747.52 |
| Total Current Assets |
2,984,874,247.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
194,766,678.11 |
| Investment Properties |
344,246,379.43 |
| Fixed Assetes |
396,762,285.95 |
| Under-construction Projects |
1,494,501.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
114,846,897.71 |
| R&D expenses |
-- |
| Goodwill |
10,868,629.12 |
| Long-Term Deferred and Prepaid Expenses |
84,714,437.08 |
| Deferred Income Tax Assets |
183,209,543.59 |
| Other Non-Current Assets |
17,995,955.49 |
| Sub-Total of Non-Current Assets |
2,747,923,412.11 |
| Total Assets |
5,732,797,659.87 |
| Short-Term Loans |
351,440,382.27 |
| Trading Financial liabilities |
-- |
| Notes Payable |
229,262,000.00 |
| Accounts Payable |
496,545,081.68 |
| Accounts Received In Advance |
4,908,735.65 |
| Employee Compensation Payable |
64,607,377.08 |
| Taxes Payable |
55,719,756.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
114,817,762.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
70,345,633.69 |
| Other Current Liabilities |
43,461,264.30 |
| Sub-Total of Current Liabilities |
1,635,703,439.86 |
| Long-term Loans |
258,187,513.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,492,984.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
282,836,274.49 |
| Total Liabilities |
1,918,539,714.35 |
| Paid-In Capital(Or Share Stock) |
574,637,150.00 |
| Capital Surplus |
2,580,955,446.07 |
| Surplus Reserve |
287,318,575.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
353,664,117.01 |
| Minority Stockholder's Interest |
-31,631,256.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,845,889,202.27 |
| Owner's Equity（Stockholder's Equity） |
3,814,257,945.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,732,797,659.87 |
